July 20, 2021
Article
Data show postoperative initiation of factor XI inhibition was effective method for reducing the risk of VTE following total knee arthroplasty.
July 15, 2021
The FDA Cardiovascular and Renal Drugs Advisory Committee cited concerns over an increase in thrombotic events.
June 21, 2021
Dabigatran etexilate was approved in both oral pellet and capsule forms for varying pediatric patient populations.
May 18, 2021
The anticoagulant did not improve clinical outcomes when compared with prophylactic anticoagulation.
May 16, 2021
Patients on atorvastatin experienced similar rates of adjudicated venous thromboembolism and all-cause mortality compared to placebo.
April 19, 2021
A new study finds patients with atrial fibrillation or venous thromboembolism were at higher risk of increased bleeding and hospitalization when treated with combination DOAC and aspirin.
April 13, 2021
FDA, CDC recommended halting use of the one-shot vaccine at all federal sites.
December 05, 2020
Investigators evaluated patients from 3 Chicago hospital systems and assessed risk factors associated with thrombosis.
November 25, 2020
Liquidia Technologies plans on addressing FDA concerns regarding treprostinil.
October 23, 2020
Compared with prophylaxis anticoagulation, full dose anticoagulation provided a greater survival benefit to those in a predominantly black population.
